Eat regular, balanced meals even when you are not hungry
Cosentino F, Grant PJ, Aboyans V, et al
Food and Drug Administration (FDA) authorized the use of Semaglutide in June 2021 for weight management in adults suffering from obesity or who are overweight and have at least one weight-related condition
Saxenda carries a boxed warning from the FDA regarding thyroid tumors
Despite this distinction, both medications offer similar benefits in weight loss, with clinical studies showing significant weight reduction, particularly with Wegovy
Beyond its powerful weight-loss potential, it directly targets critical metabolic pathways linked to aging, cognitive decline, and cardiovascular disease